chr13-33106808-C-T

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_178006.4(STARD13):​c.3174G>A​(p.Pro1058Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00432 in 1,614,036 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0035 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0044 ( 21 hom. )

Consequence

STARD13
NM_178006.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -5.43

Publications

7 publications found
Variant links:
Genes affected
STARD13 (HGNC:19164): (StAR related lipid transfer domain containing 13) This gene encodes a protein which contains an N-terminal sterile alpha motif (SAM) for protein-protein interactions, followed by an ATP/GTP-binding motif, a GTPase-activating protein (GAP) domain, and a C-terminal STAR-related lipid transfer (START) domain. It may be involved in regulation of cytoskeletal reorganization, cell proliferation, and cell motility, and acts as a tumor suppressor in hepatoma cells. The gene is located in a region of chromosome 13 that is associated with loss of heterozygosity in hepatocellular carcinomas. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Aug 2011]
STARD13 Gene-Disease associations (from GenCC):
  • schizophrenia
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 13-33106808-C-T is Benign according to our data. Variant chr13-33106808-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 791588.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-5.43 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 3 Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STARD13NM_178006.4 linkc.3174G>A p.Pro1058Pro synonymous_variant Exon 13 of 14 ENST00000336934.10 NP_821074.1 Q9Y3M8-1A0A024RDV4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STARD13ENST00000336934.10 linkc.3174G>A p.Pro1058Pro synonymous_variant Exon 13 of 14 1 NM_178006.4 ENSP00000338785.4 Q9Y3M8-1
STARD13ENST00000255486.8 linkc.3150G>A p.Pro1050Pro synonymous_variant Exon 13 of 14 1 ENSP00000255486.4 Q9Y3M8-2
STARD13ENST00000567873.2 linkc.3129G>A p.Pro1043Pro synonymous_variant Exon 13 of 14 1 ENSP00000456233.2 H3BRG5
STARD13ENST00000399365.7 linkc.2820G>A p.Pro940Pro synonymous_variant Exon 13 of 14 1 ENSP00000382300.3 Q9Y3M8-3

Frequencies

GnomAD3 genomes
AF:
0.00346
AC:
527
AN:
152210
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000700
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00144
Gnomad ASJ
AF:
0.00807
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00810
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00513
Gnomad OTH
AF:
0.00383
GnomAD2 exomes
AF:
0.00437
AC:
1097
AN:
250878
AF XY:
0.00409
show subpopulations
Gnomad AFR exome
AF:
0.000984
Gnomad AMR exome
AF:
0.00214
Gnomad ASJ exome
AF:
0.00735
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00809
Gnomad NFE exome
AF:
0.00625
Gnomad OTH exome
AF:
0.00620
GnomAD4 exome
AF:
0.00441
AC:
6449
AN:
1461708
Hom.:
21
Cov.:
31
AF XY:
0.00428
AC XY:
3114
AN XY:
727144
show subpopulations
African (AFR)
AF:
0.000657
AC:
22
AN:
33478
American (AMR)
AF:
0.00204
AC:
91
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00754
AC:
197
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.000568
AC:
49
AN:
86214
European-Finnish (FIN)
AF:
0.00754
AC:
403
AN:
53416
Middle Eastern (MID)
AF:
0.00728
AC:
42
AN:
5768
European-Non Finnish (NFE)
AF:
0.00482
AC:
5359
AN:
1111896
Other (OTH)
AF:
0.00474
AC:
286
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
340
680
1021
1361
1701
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
194
388
582
776
970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00346
AC:
527
AN:
152328
Hom.:
3
Cov.:
33
AF XY:
0.00381
AC XY:
284
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.000698
AC:
29
AN:
41576
American (AMR)
AF:
0.00144
AC:
22
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00807
AC:
28
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
0.00810
AC:
86
AN:
10616
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00513
AC:
349
AN:
68036
Other (OTH)
AF:
0.00379
AC:
8
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
27
54
80
107
134
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00440
Hom.:
2
Bravo
AF:
0.00302
Asia WGS
AF:
0.000289
AC:
1
AN:
3476
EpiCase
AF:
0.00469
EpiControl
AF:
0.00564

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jul 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

STARD13: BP4, BP7 -

Apr 12, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
0.48
DANN
Benign
0.43
PhyloP100
-5.4
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117237914; hg19: chr13-33680945; COSMIC: COSV55229933; COSMIC: COSV55229933; API